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Abstract: Previously we have investigated the cerulein-induced acute pancreatitis and 
provided data on its micro-rheological impact in the rat. We hypothesized that non-steroid 
anti-inflammatory agent flunixin, the xanthine-derivate pentoxifylline and the low molecular 
weight heparin enoxaparin may have various beneficial effects improving microcirculatory 
and rheological parameters. In female rats, under general anesthesia, 10 µg/kg cerulein s.c. 
was administered and 2 hours afterwards microcirculation was tested by laser Doppler 
flowmetry on the tongue and after performing laparotomy on the small intestine, liver and 
pancreas prior to terminal blood sampling. From blood samples hematological parameters, 
blood pH, lactate concentration, erythrocyte deformability, osmoscan parameters and 
erythrocyte aggregation were tested. Compared to normal control in acute pancreatitis group 
we found severe deterioration in tissue microcirculation together with impaired erythrocyte 
deformability and enhanced aggregation, accompanied by acidic pH and increasing lactate 
concentration. Improvement was found when using flunixin (s.c.), pentoxifylline (i.p.) or 
enoxaparin (s.c.). These drugs could partly improve the blood flux on the surface of the 
investigated organs, and the flunixin had the most expressed improving effects on micro-
rheological parameters. Surprisingly, the improving effect of pentoxifylline on micro-
rheological parameters was not obvious (red blood cell deformability did not improved better 
than in the other treated groups), however, microcirculatory parameters improved. 
Keywords: red blood cell deformability, red blood cell aggregation, osmoscan, 
microcirculation, cerulein-induced acute pancreatitis, rat model, various drug therapy 
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1. Introduction 
Although the role of microcirculation disturbances in the pathogenesis of acute 
pancreatitis is well known [6, 14, 17, 19, 25, 34, 44, 47], there are only limited number of 
studies dealing with general hemorheological or micro-rheological changes [e.g., 5, 7, 8, 22]. 
In the development of microcirculatory disturbance in severe acute pancreatitis numbers of 
cytokines, inflammatory mediators and reactive oxygen species play role [5, 9, 13, 15, 23, 25, 
28, 34, 36, 38, 39, 45, 46]. Microcirculatory disturbances of the pancreas and other organs 
may alter, or in turn, can be caused by impaired hemorheological parameters [2, 5, 7, 22, 31, 
32, 36, 42, 45]. However, it is also obvious that influencing the pancreatic microcirculation 
can be an effective option in the treatment of acute pancreatitis [12-14, 26, 27, 41]. 
In our previous study, we have investigated the cerulein-induced acute pancreatitis and 
provided data on its micro-rheological impact in the rat [22]. It was demonstrated that single 
dose of 5 or 10 µg/kg cerulein-induced acute pancreatitis in rats. The presence of acute 
pancreatitis was confirmed by the rise in amylase enzyme activity (1 and 2 hours after 
cerulein administration), as well as by histomorphological evidences. The largest magnitude 
of changes was observed in red blood cell deformability and red blood cell aggregation in the 
group with 10 µg/kg cerulein, mostly in female animals [22]. 
Therefore, as continuation, in this study we used the cerulein in 10 µg/kg in female 
animals, to compare the effects of various drugs potentially affecting tissue microcirculation 
and micro-rheological parameters. We applied tissue microcirculatory measurements and 
more complete hemorheological examination using two types of aggregometry, ektacytometry 
as well as osmotic gradient ektacytometry [10, 18, 21, 30]. 
We hypothesized that the non-steroid anti-inflammatory agent flunixin, the xanthine-
derivate pentoxifylline and the low molecular weight heparin enoxaparin may have various 
beneficial effects on improving microcirculatory and rheological parameters in this 
experimental cerulein-induced acute pancreatitis model. 
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2. Materials and methods 
2.1. Experimental animals and groups 
The experiments were approved and registered by the University of Debrecen 
Committee of Animal Research (Nr.: 16/2008), in accordance with the relevant Hungarian 
Animal Protection Act (Law XVIII/1998). 
Fifty female Sprague-Dawley rats (bodyweight: 292.1 ± 13.8 g) (Janvier Co., France) 
were randomly involved into the following experimental groups: 
I. Control group (C, n=10): tissue microcirculation measurements, blood and tissue 
samplings. 
II. Acute pancreatitis group (AP, n=10): administration of 10 µg/kg cerulein s.c., 2 hours 
later tissue microcirculation measurements, blood and tissue samplings.  
III. Acute pancreatitis + Flunixin group (AP+Fl, n=10): AP group’s procedure and 
administration of 2.5 mg/kg flunixin (Flunixin®) s.c.  
IV. Acute pancreatitis + Pentoxifylline group (AP+Pe, n=10): AP group’s procedure and 
administration of 50 mg/kg pentoxifylline (Pentoxifyllin®) i.p.  
V. Acute pancreatitis + Clexane group (AP+Cle, n=10): AP group’s procedure and 
administration of 2 mg/kg enoxaparin (Clexane®) s.c. 
 
 All animals were anesthetized using 60 mg/kg, Thiopenthal® intraperitoneally. For 
inducing acute pancreatitis, cerulein (Sigma-Aldrich Co., Budapest) dissolved in sterile 
physiological saline solution was used subcutaneously (right abdominal region) in 10 µg/kg 
dose. In Control group the same-volume sterile physiological saline solution was given 
subcutaneously. 
 
 4
2.2. Microcirculatory measurements and sampling protocol 
Two hours after administration of cerulein in Group II-V., and at the same time in 
Control Group a laser Doppler tissue flowmetry (LD-01 laser Doppler flowmeter, 
Experimetria Ltd., Hungary) with standard pencil probe was used to measure blood flux units 
(BFU) on the inferior surface of the tongue, and after completing a median laparotomy, on the 
front surface of the liver’s middle lobe, on the anti-mesenterial surface of a jejunum loop and 
on the middle region (body) of the pancreas. At all measurement points after stabilization of 
the signal, BFU values were recorded for 20 sec, and the average values of these periods were 
analyzed off-line. In parallel rectal temperature was measured. 
Following microcirculatory measurements, blood sampling of 3-5 ml blood was 
completed by cardiac puncture (24 G needle; anticoagulant: K3-EDTA, 1.5 mg/ml). 
 
2.3. Laboratory investigations 
A Sysmex F-800 semi-automated microcell counter (TOA Medical Electronics Co., 
Japan) was used to determine hematological parameters, from which white blood cell count 
(WBC [x103/µl]), red blood cell count (RBC [x106/µl]), hematocrit (Hct [%]), mean corpuscular 
volume (MCV [fl]) and platelet count (Plt [x103/µl]) were analyzed in this study. 
An ABL555 blood gas analyzer automate (Radiometer Copenhagen, Denmark) was 
used to measure blood pH and lactate concentration [mmol/l]. 
A LoRRca MaxSis Osmoscan device (Mechatronics BV, The Netherlands) was used 
to measure red blood cell deformability. For regular red blood cell deformability tests 5 µl 
blood sample was gently mixed in 1 ml of isotonic polyvinyl-pyrrolidone solution (360 kDa 
PVP in normal PBS; viscosity = 27 mPa.s, osmolarity = 290-300 mOsm/kg ; pH ~7.3). 
During the measurements, the laser diffraction pattern was analyzed while the device 
generated shear stress (SS) range from 0.3 to 30 Pa. The elongation index (EI) is equal to (L-
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W)/(L+W), where L is the length and W is the width of the diffractogram. EI increases with 
red blood cell deformability [3, 18]. The tests were carried out at constant temperature of 37 
°C. For comparison of the results, Lineweaver-Burk analyses were also performed, 
calculating the maximal elongation index (EImax) and the shear stress at half EImax (SS1/2 [Pa]) 
values, according to the following formula: 1/EI = SS1/2 / EImax x 1/SS + 1/EImax [4].  
For the osmotic gradient ektacytometry (osmoscan) measurements 250 µl blood was 
required. During the measurements a constant shear stress of 30 Pa was used for continuous 
measurement of EI values, while the osmotic environment is changed by the device, using 
various, controlled mixture of 0 and 500 mOsmol/kg PVP solutions. In this study we analyzed 
the minimal elongation index values measured at low osmolar environment (minimal EI), 
maximal elongation index values (maximal EI), half of the maximal elongation index values 
at high osmolar environment (EIhyper) and the relevant osmolarity values [10, 18]. 
Red blood cell aggregation was tested based on light-transmittance method using a 
Myrenne MA-1 erythrocyte aggregometer (Myrenne GmbH, Germany) with determination of 
aggregation index values M (at shear rate of 0 s-1) and M1 (at shear rate of 3 s-1) 5 or 10 
seconds after disaggregation. The indices (M 5 s, M1 5s, M 10 s, M1 10 s) increase with 
enhanced red blood cell aggregation [3, 18]. In parallel the LoRRca device was also used to 
measure red blood cell aggregation parameters by syllectometry: amplitude (Amp), 
aggregation index (AI) and the aggregation half-time (t1/2 [s]) [18]. The aggregation 
measurement were carried out in native blood samples without hematocrit adjustment. 
 
2.3. Statistical analyses 
Data are presented as mean ± standard deviation (S.D.). Depending on the normality 
of data distribution, Student’s t-test or Mann-Whitney RS test was used for inter-group 
comparison. A p<0.05 was considered as statistically significant. 
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3. Results 
3.1. Microcirculatory and body temperature changes 
The comparisons have two dimensions: control versus acute pancreatitis, and 
comparing acute pancreatitis groups without or with various treatments. 
When measuring blood flux on tongue, liver, intestine and pancreas, we found that 
acute pancreatitis presented lower BFU values compared to healthy control animals (Figure 
1). On the tongue all the groups with acute pancreatitis showed lower BFU values compared 
to Control (p<0.001), but did not express statistically significant differences (Figure 1A).  
On the small bowel the same situation could be observed compared to Control 
(p<0.001) (Figure 1B). On the liver, compared to Control significant difference was found in 
AP group (p<0.001), in AP+Pe (p=0.026) and in AP+Cle group (p<0.001) (Figure 1C). These 
observation suggest that on remote organs the drugs used could not improve the blood flux 
values, expect for flunixin when measuring surface BFU values of the intestine and the liver.  
In case of the pancreas, significant difference could be seen only in the AP group 
versus Control (p=0.039), suggesting that here all of these drugs could moderately improve 
the BFU values (Figure 1D). 
Since laser Doppler flowmetry results are affected by the temperature, we measured 
the body temperature: it was 35.29 ± 0.36 °C in Control group, 38.05 ± 0.66 °C in AP 
(p<0.001 vs. Control), 36.49 ± 1.34 °C in AP+Fl, 40.03 ± 0.78 °C in AP+Pe (p<0.001 vs. all 
groups), and 37.26 ± 0.94 °C in AP+Cle group (p=0.002 vs. Control). The high values in 
AP+Pe group was obvious even when touching the animals (room temperature was 25.95 °C). 
 
3.2. Changes of hematological parameters 
Table 1 summarizes the selected hematological parameters. Compared to Control, all 
acute pancreatitis groups showed lower white blood cell count (WBC [x103/µl]), except for 
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the group treated with enoxaparin (AP+Cle group), where WBC was elevated (p<0.001 vs. 
Control and vs. other groups). 
Red blood cell count (RBC [x106/µl]) rose only in AP+Pe group (p=0.008 vs. Control) 
and AP+Cle group (p<0.001 vs. Control), which changes were accompanied by similar 
alterations in the hematocrit (Hct [%]). Hct values of AP+Pe and AP+Cle groups were 
significantly higher compared to Control (p=0.001 and p<0.001), AP (p=0.007 and p=0.002) 
as well as AP+Fl groups (p=0.021 and p=0.027), respectively. The mean corpuscular volume 
(MCV [fl]) did not show important differences. 
Platelet counts (Plt [x103/µl]) were elevated in all acute pancreatitis groups, showing 
the highest values in AP+Cle group (p<0.001 vs. Control; p<0.001 vs. AP; p=0.022 vs. 
AP+Fl; p=0.001 vs. AP+Pe). 
 
3.3. Changes of blood pH and lactate concentration 
Blood pH significantly dropped in AP group (p=0.022 vs. Control), while the values of 
the treated groups were closer to the Control ones (Figure 2A). 
Lactate concentration elevated slightly in AP and AP+Fl group without significant 
difference, while in AP+Pe group it significantly showed the highest values (p<0.001 vs. 
Control; p=0.006 vs. AP; p=0.007 vs. AP+Cle). The AP+Cle group did not differ from the 
Control (Figure 2B). 
 
3.4. Changes of red blood cell deformability 
Elongation index (EI) values decreased in groups with acute pancreatitis, except for 
the one treated with flunixin. Compared to the healthy Control group, the calculated EImax 
values were significantly lower in AP (p=0.037), in AP+Pe (p<0.001) and in AP+Cle 
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(p=0.014) groups. Values of AP+Fl group were significantly higher versus AP (p<0.001), 
AP+Pe (p<0.001) and AP+Cle (p<0.001) groups (Figure 3A). 
The calculated SS1/2 values [Pa] showed similar relations: they were significantly 
lower versus Control in AP (p<0.001), AP+Pe (p<0.001) and AP+Cle (p<0.001) groups, and 
in AP+Fl group the values were significantly higher versus AP (p<0.001), AP+Pe (p<0.001) 
and AP+Cle (p<0.001) groups (Figure 3B). 
As a sum, both EImax and SS1/2 decreased in acute pancreatitis being without or with 
treatment, except for the group with flunixin, where the values were closed to the Control. 
When testing osmoscan parameters (Table 2), we found that minimal EI values were 
the highest in AP+Cle group (p<0.001 vs. Control; p=0.002 vs. AP; p<0.043 vs. AP+Fl and 
p<0.001 vs. AP+Pe), while the maximal EI values were the lowest in AP+Fl group (p=0.002 
vs. Control; p=0.026 vs. AP and p=0.002 vs. AP+Pe). EIhyper values were also the lowest in 
Ap+Fl group (p=0.008 vs. Control; p=0.031 vs. AP and p=0.002 vs. AP+Pe).  
Osmolarity values at maximal EI (‘optimal’ osmolarity) did not show important 
differences. Interestingly, we found significant differences in osmolarity values of AP+Fl 
group at minimal EI (p=0.013 vs. Control; p=0.01 vs. AP; p=0.004 vs. AP+Pe; and p=0.006 
vs. AP+Cle). Osmolarity values at EIhyper were the highest in Ap+Pe group (p=0.011 vs. 
Control; p=0.011 vs. AP; p=0.001 vs. AP+Fl and p=0.002 vs. AP+Pe).  
 
3.5. Changes of red blood cell aggregation 
Table 3 summarizes the results from light-transmission aggregometry and 
syllectometrial measurements. 
Compared to the healthy Control, red blood cell aggregation index values M and M1 
showed increase in all acute pancreatitis groups, with the largest magnitude in the untreated 
AP group. In case of M 5 s values the differences were significant in AP (p<0.001), in AP+Fl 
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(p<0.001) and in AP+Cle (p=0.002) groups. M1 5s values showed definitive differences in 
AP (p=0.001) and in AP+Pe groups (p<0.001). Testing M 10 s values, the differences were 
similar, being significant versus Control in AP (p<0.001), in AP+Fl (p=0.023) and in AP+Cle 
(p<0.001) groups. Compared to Control, M1 10 s values were found to be significantly higher 
in AP (p<0.001), AP+Fl (p=0.022), in AP+Cle (p=0.023) and in AP+Pe groups (p<0.001). 
The latter values were much higher compared to the other acute pancreatitis groups, too 
(p<0.001 vs. all). 
Using the LoRRca, we found that all group with acute pancreatitis expressed elevated 
AI values. Compared to the Control, the differences were significant in AP (p=0.002), in 
AP+Fl (p=0.025) and in AP+Pe (p=0.014) groups. AI values did not show significant 
differences, while t1/2 values [s] expressed significant alteration only between AP+Pe and 
AP+Cle groups (p=0.044). 
 
4. Discussion 
The cerulein-induced acute pancreatitis model is widely used in rats, mice, Syrian 
hamsters and dogs [11, 16, 17, 36, 38, 39]. However, the ‘effective’ dosage of cerulein is 
controversial [5, 13, 22, 46]. Based on the results of our previous study [22] we used 10 µg/kg 
single-dose cerulein subcutaneously in rats, and had the samples 2 hours afterwards. By this 
protocol we could investigate the early phase of the acute pancreatitis [25, 34]. 
The most accepted theories in the pathomechanism of severe acute pancreatitis include 
pancreatic autodigestion, leukocyte activation induced inflammation, bacterial translocation 
and pancreatic microcirculatory disturbances [5, 13, 14, 24, 25, 28, 34, 35, 36, 38, 39]. It is 
known, that during the early phase of the acute pancreatitis there is vasoconstriction in the 
larger pancreatic vessels resulting in a reduced capillary flow with increased permeability, 
which is followed by capillary stasis, hemorrhage in the late phase [25, 34]. Inflammatory 
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cytokines and formation of microthrombi as well as the edematous changes also lead to the 
deteriorated microcirculation [1, 25, 37]. Zhou et al. noticed in cerulein-induced acute 
pancreatitis the decrease of blood flow, functional capillary density and intermittent irregular 
perfusion in the pancreas [47].  
Our microcirculatory findings correlated well with the literature data, the blood flux in 
the pancreas decreased 2-hours after administration of the cerulein. In remote regions (tongue, 
liver, intestine) we could also observed decreased blood flux values, suggesting a generalized 
inflammatory response [1, 25, 37, 44]. Activation of inflammatory cells leads to deliberation 
of pro-inflammatory mediators (TNF-α, IL-1, IL-2, IL-6) as well as NO, reactive oxygen 
radicals and arachidonic acid metabolites, besides anti-inflammatory IL-10. These factors 
together with various chemochines, such as IL-8 and chemoattractant proteins, lead to a 
systemic inflammatory response [6, 17, 19, 25, 35, 44]. These generalized changes may 
support the observation of decreased blood flux values on the surface of the investigated 
remote organs, as well as the increased body temperature. 
Concerning the blood rheological changes during acute pancreatitis, there are not so 
many articles in the available literature. In the early phase –together with microcirculatory 
changes– their investigation was an important aim of our study.  
In the pathophysiology of the acute pancreatitis the cascade system starts by the 
expression of inflammatory and vasoactive mediators such as platelet activation factor, 
intracellular adhesion molecule-1, endothelin, tumor necrosis factor, nitric oxide, oxygen free 
radicals, thromboxanes, bradykinin, prostaglandins and others [15, 23, 26, 33-40]. 
Inflammatory processes, oxidative damage, changes in pH, lactate concentration, 
oxygenation, all may have impact on red blood cell micro-rheological properties [2, 5, 7, 29]. 
In our study we could see definitive decrease in blood pH of the acute pancreatitis 
group being without treatment. It is known that alteration is pH affect red blood cell 
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deformability and aggregation [2, 29]. During inflammatory processes the free radical 
reactions as well as local changes of fluid distribution and micro-environmental osmolarity 
may also alter the rheological parameters [2, 7, 9, 31]. And in turn, altered blood rheology has 
an impact on the microcirculation [32]. Thus, parallel investigation of micro-rheological and 
microcirculatory alterations may have informative values on better understanding the 
pathophysiological events and to compare therapeutic tools.  
We found that red blood cell deformability decreased (note that both EImax and SS1/2 
decreases, because of the shape of the EI-SS curve) and erythrocyte aggregation enhanced in 
the samples from acute pancreatitis group. We did not make hematocrit adjustment for the 
aggregation measurements. The average hematocrit varied between 39 and 43 °%, and the 
available blood samples volume did not allow to perform e.g. 40% red blood cell plasma 
suspensions for all the aggregation measurements (note that just the LoRRca needs 
approximately 1 ml of sample for the aggregation test).  
Further aim was to investigate whether various drugs may have improving effect on 
microcirculatory and micro-rheological changes induced by acute pancreatitis.  
There are many possible ways (e.g., heparin, low molecular weight heparin [LMWH], 
pentoxifylline, allopurinol, baicalin, tirilazad mesylate, bovine hemoglobin, mesenteric lymph 
duct ligation, etc.) to affect the development of microcirculatory disturbances in experimental 
acute pancreatitis [5, 8, 13, 14, 16, 20, 33, 38, 39]. 
In our study, we found that the non-steroid anti-inflammatory agent flunixin, which is 
widely used in the veterinary practice, had beneficial impact to reduce the micro-rheological 
impairment, supposedly by reducing the general effects of the inflammatory processes [1, 25, 
34, 37]. It is known that free radical reactions originated from the inflammatory events may 
have impair red blood cell micro-rheological properties [2, 7, 9]. Interestingly, both the red 
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blood cell deformability and aggregation parameters could be improved in the group treated 
with flunixin. 
There are numerous clinical and experimental studies on the effects of pentoxifylline 
on acute pancreatitis [15, 16, 26, 27]. In experimental studies pentoxifylline –during the 
decrease of the secretion of inflammatory mediators– reduces systemic and local 
inflammatory responses and mortality [e.g., 15, 16]. Pentoxifylline as a phosphodiesterase 
inhibitor regulates the intra-pancreatic protein serine/threonine phosphatase activity and 
inflammatory mediators that play an important role in the pathomechanism of acute 
pancreatitis, too [15, 16, 26, 43]. Another well-known and important effect this drug is the 
improvement of red blood cell deformability, increase in filterability [e.g., 42]. However, in 
this current study we did not found direct evidence for the improving effect on red blood cell 
deformability in the present acute pancreatitis rat model. As an additional surprise, the body 
temperature was the highest in the AP+Pe group, probably due to the moderate 
microcirculatory and micro-rheological improvement but together with the existing 
inflammatory processes. 
A positive effect of heparin was observed on the microcirculation of the pancreas in 
these studies [13, 14, 33]. In clinical studies, LMWH decreased the severity and the rate of 
encephalopathy as well as the mortality in severe acute pancreatitis [23, 24]. The possible 
effect of LMWH may be the downregulation of endothelin-1, TNF-α and IL-6 that reduced 
the formation of microthrombi in the pancreas and other organs [24, 33]. 
 
5. Conclusion 
Investigation of microcirculation of local and remote tissues together with the analysis 
of hemorheological parameters and certain metabolic factors could be performed in this 
cerulein-induced acute pancreatitis model. Concluding the result: 2 hours after administration 
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of the cerulein (10 µg/kg, s.c.), we found severe deterioration in tissue microcirculation 
(tongue, liver, small intestine and pancreas), together with impaired red blood cell 
deformability and enhanced red blood cell aggregation, accompanied by acidic pH level and 
increasing lactate concentration compared to normal control. Improvement could be seen 
when using flunixin, pentoxifylline or enoxaparin, however, not in the same manner. These 
drugs could partly improve the blood flux on the surface of the investigated organs, however, 
the non-steroid anti-inflammatory drug flunixin had the most expressed improving effects on 
micro-rheological parameters (both on red blood cell deformability and aggregation). 
Surprisingly, the improving effect of pentoxifylline on micro-rheological parameters was not 
obvious (red blood cell deformability did not improved better than in the other treated 
groups), however, microcirculatory parameters improved.  
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8. Tables 
Table 1.  Changes of selected hematological parameters 
Variable Control AP AP+Fl AP+Pe AP+Cle 
WBC [x103/µl] 3.74 ± 1.28 3.22 ± 1.18 3.4 ± 1.05 2.93 ± 0.69 5.15 ± 1.6 *# 
RBC [x106/µl] 6.85 ± 0.51 6.99 ± 0.41 6.91 ± 0.81 7.34 ± 0.58 * 7.47 ± 0.47 * 
Hct [%] 39.03 ± 2.29 39.9 ± 1.98 39.14 ± 4.54 42.23 ± 3.49 *# 42.29 ± 2.5 *# 
MCV [fl] 57 ± 1.78 57.08 ± 1.79 56.66 ± 1.34 57.47 ± 1.25 56.62 ± 1.77 
Plt [x103/µl] 775.6 ±170.4 831.3 ± 87.4 866.1 ± 132.9* 835.9 ± 116.2 954 ± 96.1 *# 
means ± S.D.;  * p<0.05 vs. Control,  #  vs. other groups 
 
Table 2. Parameters of osmotic gradient ektacytometry measurements at shear stress of 30 Pa. 
Variable Control AP AP+Fl AP+Pe AP+Cle 
Minimal EI 0.103 ± 0.008 0.104 ± 0.008 0.107 ± 0.011 0.103 ± 0.008 0.116 ± 0.005*# 
Maximal EI 0.514 ± 0.008 0.511 ± 0.005 0.497 ± 0.014* 0.516 ± 0.006 0.508 ± 0.007 
EIhyper 0.257 ± 0.004 0.256 ± 0.003 0.248 ± 0.007* 0.258 ± 0.003 0.254 ± 0.004 
Osmolarity at min. 
EI [mOsm/kg] 
162.3 ± 5.5 164.4 ± 6.5 136.5 ± 33.6*# 165.1 ± 4.8 162.1 ± 3.9 
Osmolarity at max. 
EI [mOsm/kg] 
312.5 ± 10.3 319.4 ± 14.9 313.6 ± 13.9 313.8 ± 9.1 318 ± 13.3 
Osmolarity at EIhyper 
[mOsm/kg] 
412.9 ± 6.9 412.7 ± 6.8 408.3 ± 8.6 420.9 ± 6.1*# 411.8 ± 4.9 
means ± S.D.;  * p<0.05 vs. Control,  #  vs. other groups 
 
Table 3. Red blood cell aggregation parameters measured by LoRRca (Amp, AI, t1/2) or 
Myrenne MA-1 aggregometer (M and M1 index values at 5 and 10 sec) 
Variable Control AP AP+Fl AP+Pe AP+Cle 
Amplitude [AU] 6.59 ± 1.81 9.76 ± 2.05 * 9.16 ± 2.78 * 8.8 ± 1.78 * 8.4 ± 2.19 
AI [%] 70.77 ± 11.9 69.37 ± 5.29 71.39 ± 9.22 73.38 ± 4.97 76.62 ± 6.07 
t1/2 [sec] 0.66 ± 0.62 0.94 ± 0.47 1.04 ± 0.75 0.85 ± 0.41 0.52 ± 0.25 
M 5 sec [AU] 1.44 ± 0.81 2.51 ± 0.98 * 1.66 ± 0.71 1.95 ± 1.27 2.14 ± 0.99 * 
M1 5 sec [AU] 2.07 ± 0.95 2.88 ± 1.15 * 2.82 ± 1.84 4.14 ± 1.17 * 2.31 ± 0.6 
M 10 sec [AU] 4.31 ± 1.73 6.98 ± 2.35 * 6.02 ± 3.16 * 5.34 ± 3.56 7.14 ± 2.52 * 
M1 10 sec [AU] 5.12 ± 2.15 8.85 ± 3.84 * 7.14 ± 3.75 * 11.33 ± 2.18*# 5.95 ± 1.68* 
means ± S.D.;  * p<0.05 vs. Control,  #  vs. other groups 
AI = aggregation index; AU = arbitrary unit 
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9. Figure captions 
 
Figure 1. 
Blood flux units measured on the surface of tongue (A), small intestine (B), liver (C) and 
pancreas (D) in Control group, acute pancreatitis group (AP), acute pancreatitis + flunixin 
group (AP+Fl), acute pancreatitis + pentoxifylline group (AP+Pe) and in acute pancreatitis + 
clexane group (AP+Cle). 
means ± S.D.;  * p<0.05 vs. Control 
 
Figure 2. 
Blood pH (A) and lactate concentration [mmol/l] (B) in Control group, acute pancreatitis 
group (AP), acute pancreatitis + flunixin group (AP+Fl), acute pancreatitis + pentoxifylline 
group (AP+Pe) and in acute pancreatitis + clexane group (AP+Cle). 
means ± S.D.;  * p<0.05 vs. Control; # p<0.05 vs. other groups 
 
Figure 3. 
Calculated EImax (A) and shear stress values at half-EImax [Pa] (B) in Control group, acute 
pancreatitis group (AP), acute pancreatitis + flunixin group (AP+Fl), acute pancreatitis + 
pentoxifylline group (AP+Pe) and in acute pancreatitis + clexane group (AP+Cle). 
means ± S.D.;  * p<0.05 vs. Control; # p<0.05 vs. other groups 
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